THE SCIENCE OF YOUTHFUL LONGEVITY
Live younger,
for longer.
Healthspan, not just lifespan. Strength, cognition, energy and the cellular vitality beneath them, decoded from the newest longevity science.
Hallmarks of aging
Cellular reprogramming
Senolytics
GLP-1 & metabolism
Biological age clocks
VO₂ max & muscle
NAD⁺ & mitochondria
Inflammaging
Brain health
Gene therapy
Our thesis
Lifespan is a number. Healthspan is a life.
Medicine has added decades to the average life, yet many of those extra years are spent with low energy, frailty, pain or cognitive decline. Adding years without adding function was never the goal.
Youthful longevity means compressing decline into the shortest possible window at the very end, and staying strong, sharp and independent until then. The science of how to do that is moving faster than ever. This site tracks it.
The healthspan gap, in numbers
We are living longer. We are not living better for long enough.
9.6 years
Average gap between lifespan and healthspan worldwide: years lived in poor health.
12.4 years
The US healthspan-lifespan gap, the largest of 183 WHO member states.
80% lower
Adjusted risk of death in the fittest vs least-fit adults among 122,007 people treadmill-tested.
16% higher
Risk of death for every 5 kg lower grip strength, in nearly 140,000 adults across 17 countries.
The Youthful Longevity standard
Five capacities that make a long life worth living.
We measure longevity by what you can still do, not just how long you last. Every update on this site maps back to at least one of these pillars.
01
Performance
Cardiorespiratory fitness (VO₂ max) is one of the strongest predictors of how long and how well people live.
02
Cognition
Memory, focus and processing speed, protected through sleep, vascular and metabolic health.
03
Muscle & bone strength
Muscle, bone and joints that keep you powerful, mobile and independent into your 90s.
04
Metabolic health
Stable glucose, healthy body composition and low inflammation, the soil every other pillar grows in.
05
Cellular vitality
Mitochondria, DNA repair and cleanup systems: the regenerative engine inside every cell.
The biology of aging
Twelve hallmarks. One cell at a time.
Scientists now describe aging as twelve interconnected processes inside our cells. Tap each one to see what goes wrong and which levers researchers are testing.
Emerging therapeutics
The new frontier, with honest evidence labels.
From exercise to epigenetic reprogramming, each therapy is tagged by how far the human evidence actually goes.
Established
Exercise and resistance training
The best-evidenced healthspan intervention we have: aerobic fitness plus strength.
Established
Sleep, nutrition and caloric restriction
Daily inputs that shape metabolic aging; the strongest data are for caloric restriction.
Approved for other uses
GLP-1 receptor agonists
Obesity and diabetes drugs with proven heart benefits and an open question on aging.
Approved for other uses
Metformin and the TAME trial
A low-cost diabetes drug proposed as the first test case for treating aging itself.
Approved for other uses
Rapamycin and mTOR inhibitors
The most consistent lifespan extender in animals, now in early human testing.
In human trials
Senolytics
Drugs that clear senescent “zombie” cells, with mixed but growing human data.
The research desk
What changed in longevity science this month.
Every update summarizes a primary source, labels the evidence level, and says plainly what it does not prove.
Senescence
Senolytic combo improves liver fibrosis in small placebo-controlled trial
In a phase 2, double-blind trial of 31 adults with fibrotic MASH (fatty-liver inflammation), intermittent dasatinib plus quercetin improved fibrosis by at least one stage in 47% of treated participants versus 7% on placebo, judged by paired liver biopsies. Tissue sequencing showed lower senescence and fibrosis gene signatures in the treated group.
Human RCT
Cellular Reprogramming
First human trial of partial epigenetic reprogramming doses its first patient
Life Biosciences reported dosing the first participant in a Phase 1 trial of ER-100, an eye-injected gene therapy that switches on three Yamanaka factors (OCT4, SOX2, KLF4) in people with glaucoma or NAION, a stroke-like injury of the optic nerve. The FDA cleared the company’s IND application, announced January 28, 2026, and the study’s goals are safety, tolerability and visual function.
Early human trial
Metabolic & GLP-1
Semaglutide slowed blood-based aging clocks in a post hoc trial analysis
Researchers re-analyzed blood DNA methylation from a 32-week placebo-controlled trial of semaglutide in 84 adults with HIV-associated fat redistribution. Several aging clocks moved in the younger direction with semaglutide, including PhenoAge and a roughly 9% slower DunedinPACE pace of aging.
Human RCT (post hoc)
The Longevity Forum
Ideas from the people moving the field.
Our original series, Youthful Conversations, sits alongside curated public lectures from leading longevity scientists.
Who this is for
One evidence base, three ways in.
01
For the curious public
Plain-language explainers on how aging works and which headlines deserve your attention, with every claim tied to a source.
02
For executives and high performers
Your edge depends on energy, focus and recovery. Track the therapies and biomarkers that matter for performance, then plan with a physician.
03
For clinicians and thought leaders
A curated research desk, evidence labels you can share with patients, and a Forum for recorded expert conversations.
Why we built this
“Longevity medicine is full of promise and full of noise. Our job is to separate the two, so you can make decisions with your physician based on evidence, not hype.”
Farhan Tahir, MD, FACR, Dip. ABOM
Founder, Youthful Vitality & Longevity Medicine®
Quadruple board-certified in internal medicine, rheumatology, integrative medicine and obesity medicine, with more than 20 years in academic, hospital and integrative practice. Rheumatology fellowship at the University of Michigan, where his interest in longevity medicine began.
The Youthful Longevity Brief
The science of staying young, in your inbox every two weeks.
New research, decoded in five minutes, with evidence labels and zero hype.
We will never sell, rent or share your information. Unsubscribe anytime.